187 related articles for article (PubMed ID: 21423621)
1. Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway.
Guo CP; Liu KW; Luo HB; Chen HB; Zheng Y; Sun SN; Zhang Q; Huang L
PLoS One; 2011 Mar; 6(3):e17734. PubMed ID: 21423621
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53.
Guo C; Liu K; Zheng Y; Luo H; Chen H; Huang L
Apoptosis; 2011 Jun; 16(6):606-18. PubMed ID: 21475994
[TBL] [Abstract][Full Text] [Related]
3. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK
Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Slebos RJ; Lee MH; Plunkett BS; Kessis TD; Williams BO; Jacks T; Hedrick L; Kastan MB; Cho KR
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5320-4. PubMed ID: 8202487
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.
Melillo RM; Helin K; Lowy DR; Schiller JT
Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161
[TBL] [Abstract][Full Text] [Related]
6. Study on the carcinogenic mechanism of human papillomavirus typel6 E7 protein in cervical carcinoma.
Wang P; Peng Z; Wang H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):117-20. PubMed ID: 11503038
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins.
Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Melvin J; Troutman S; Kissil JL; Huryn DM; Marmorstein R
Chem Biol; 2012 Apr; 19(4):518-28. PubMed ID: 22520758
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
11. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
12. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
13. Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells.
Henry D; Brumaire S; Hu X
Leuk Res; 2019 Feb; 77():34-41. PubMed ID: 30641474
[TBL] [Abstract][Full Text] [Related]
14. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression.
Pei Z; Zeng J; Gao Y; Li F; Li W; Zhou H; Yang Y; Wu R; Chen Y; Liu J
Oncol Rep; 2016 Jul; 36(1):291-8. PubMed ID: 27176229
[TBL] [Abstract][Full Text] [Related]
17. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
18. Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.
Todorovic B; Hung K; Massimi P; Avvakumov N; Dick FA; Shaw GS; Banks L; Mymryk JS
J Virol; 2012 Dec; 86(24):13313-23. PubMed ID: 23015707
[TBL] [Abstract][Full Text] [Related]
19. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes.
Cayrol C; Lacroix C; Mathe C; Ecochard V; Ceribelli M; Loreau E; Lazar V; Dessen P; Mantovani R; Aguilar L; Girard JP
Blood; 2007 Jan; 109(2):584-94. PubMed ID: 17003378
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
